{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:20:48Z","timestamp":1794673248984,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014215","name":"Huxiang Youth Talent Support Program","doi-asserted-by":"publisher","award":["2022RC1014"],"award-info":[{"award-number":["2022RC1014"]}],"id":[{"id":"10.13039\/501100014215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ20084"],"award-info":[{"award-number":["2025JJ20084"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23416-6","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:55:44Z","timestamp":1759920944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hospital spending for cancers in Hunan, China during 2017 and 2019"],"prefix":"10.1186","volume":"25","author":[{"given":"Mengyao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"23416_CR1","doi-asserted-by":"publisher","first-page":"838911","DOI":"10.3389\/fonc.2022.838911","volume":"12","author":"O Novoplansky","year":"2022","unstructured":"Novoplansky O, Jagadeeshan S, Regev O. Worldwide prevalence and clinical characteristics of RAS mutations in head and neck cancer: a systematic review and meta-analysis. Front Oncol. 2022;12:838911. https:\/\/doi.org\/10.3389\/fonc.2022.838911.","journal-title":"Front Oncol"},{"issue":"1","key":"23416_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","volume":"39","author":"RM Feng","year":"2019","unstructured":"Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond). 2019;39(1):22. https:\/\/doi.org\/10.1186\/s40880-019-0368-6.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"23416_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12025","volume":"40","author":"M Cao","year":"2020","unstructured":"Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun. 2020;40(5):205\u201310. https:\/\/doi.org\/10.1002\/cac2.12025.","journal-title":"Cancer Commun"},{"key":"23416_CR4","doi-asserted-by":"publisher","first-page":"3918045","DOI":"10.1155\/2022\/3918045","volume":"2022","author":"SZ Zhang","year":"2022","unstructured":"Zhang SZ, Zhang L, Xie L. Cancer burden in China during 1990\u20132019: analysis of the global burden of disease. Biomed Res Int. 2022;2022:3918045. https:\/\/doi.org\/10.1155\/2022\/3918045.","journal-title":"Biomed Res Int"},{"key":"23416_CR5","doi-asserted-by":"publisher","first-page":"942911","DOI":"10.3389\/fpubh.2022.942911","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Fu Y, Chen M, Si L. Socioeconomic inequality in health care use among cancer patients in China: evidence from the China health and retirement longitudinal study. Front Public Health. 2022;10:942911. https:\/\/doi.org\/10.3389\/fpubh.2022.942911.","journal-title":"Front Public Health"},{"issue":"3","key":"23416_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"23416_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037\u201348. https:\/\/doi.org\/10.1002\/cac2.12197.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"23416_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390. https:\/\/doi.org\/10.1097\/CM9.0000000000002108.","journal-title":"Chin Med J (Engl)"},{"issue":"33","key":"23416_CR9","doi-asserted-by":"publisher","first-page":"e16718","DOI":"10.1097\/MD.0000000000016718","volume":"98","author":"GL Yuan","year":"2019","unstructured":"Yuan GL, Liang LZ, Zhang ZF, et al. Hospitalization costs of treating colorectal cancer in China: a retrospective analysis. Medicine (Baltimore). 2019;98(33):e16718. https:\/\/doi.org\/10.1097\/MD.0000000000016718.","journal-title":"Medicine (Baltimore)"},{"key":"23416_CR10","doi-asserted-by":"publisher","first-page":"917119","DOI":"10.3389\/fpubh.2022.917119","volume":"10","author":"X Ke","year":"2022","unstructured":"Ke X, Lin W, Li D, et al. Spending and hospital stay for melanoma in Hunan, China. Front Public Health. 2022;10:917119. https:\/\/doi.org\/10.3389\/fpubh.2022.917119.","journal-title":"Front Public Health"},{"issue":"3","key":"23416_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.31662\/jmaj.2022-0007","volume":"5","author":"T Konishi","year":"2022","unstructured":"Konishi T, Fujiogi M, Michihata N, et al. Association of operative day of the week with the length of stay and total hospitalization costs in patients with partial mastectomy: a nationwide database study in Japan. JMA J. 2022;5(3):319\u201327. https:\/\/doi.org\/10.31662\/jmaj.2022-0007.","journal-title":"JMA J"},{"key":"23416_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vhri.2021.12.003","volume":"30","author":"GG Liu","year":"2022","unstructured":"Liu GG, Wu J, He X, Jiang Y. Policy updates on access to and affordability of innovative medicines in China. Value Health Reg Issues. 2022;30:59\u201366. https:\/\/doi.org\/10.1016\/j.vhri.2021.12.003.","journal-title":"Value Health Reg Issues"},{"issue":"7","key":"23416_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783\u201391. https:\/\/doi.org\/10.1097\/CM9.0000000000001474.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"23416_CR14","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.12102\/j.issn.1009-6493.2023.10.014","volume":"37","author":"M Zhao","year":"2023","unstructured":"Zhao M, Wang Y. Research on urban cancer early diagnosis and treatment project in China. Chin Nurs Res. 2023;37(10):1765\u201371. https:\/\/doi.org\/10.12102\/j.issn.1009-6493.2023.10.014.","journal-title":"Chin Nurs Res"},{"key":"23416_CR15","doi-asserted-by":"publisher","unstructured":"Cao MM, Chen WQ. Current status of cancer screening in China. Sci Technol Rev. https:\/\/doi.org\/10.3981\/j.issn.1000-7857.2023.18.002.","DOI":"10.3981\/j.issn.1000-7857.2023.18.002"},{"issue":"3","key":"23416_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/1759-7714.12147","volume":"6","author":"T Yu","year":"2015","unstructured":"Yu T, He Z, Zhou Q, Ma J, Wei L. Analysis of the factors influencing lung cancer hospitalization expenses using data mining. Thorac Cancer. 2015;6(3):338\u201345. https:\/\/doi.org\/10.1111\/1759-7714.12147.","journal-title":"Thorac Cancer"},{"issue":"3","key":"23416_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/cancers15030664","volume":"15","author":"W Januszewicz","year":"2023","unstructured":"Januszewicz W, Turkot MH, Malfertheiner P, Regula J. A global perspective on gastric cancer screening: which concepts are feasible, and when? Cancers (Basel). 2023;15(3):664. https:\/\/doi.org\/10.3390\/cancers15030664.","journal-title":"Cancers (Basel)"},{"key":"23416_CR18","doi-asserted-by":"publisher","first-page":"e43586","DOI":"10.2196\/43586","volume":"9","author":"L Wang","year":"2023","unstructured":"Wang L, Wang Y, Wang F, et al. Disparity in Lung cancer screening among smokers and nonsmokers in China: prospective cohort study. JMIR Public Health Surveill. 2023;9:e43586. https:\/\/doi.org\/10.2196\/43586.","journal-title":"JMIR Public Health Surveill"},{"issue":"9","key":"23416_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/10826084.2020.1750031","volume":"55","author":"Y Hu","year":"2020","unstructured":"Hu Y, Zhong R, Li H, Zou Y. Effects of betel quid, smoking and alcohol on oral cancer risk: a case-control study in Hunan Province, China. Subst Use Misuse. 2020;55(9):1501\u20138. https:\/\/doi.org\/10.1080\/10826084.2020.1750031.","journal-title":"Subst Use Misuse"},{"issue":"9","key":"23416_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.11735\/j.issn.1004-0242.2019.09.A008","volume":"28","author":"Y Peng","year":"2019","unstructured":"Peng Y, Liu J, Xu K, et al. Incidence and mortality of oral cancer in registry regions of Hunan Province, 2009\u20132015. China Cancer. 2019;28(9):680\u20138. https:\/\/doi.org\/10.11735\/j.issn.1004-0242.2019.09.A008.","journal-title":"China Cancer."},{"issue":"10","key":"23416_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.11735\/j.issn.1004-0242.2023.10.A006","volume":"32","author":"R Sun","year":"2023","unstructured":"Sun R, Li S, Xu X, et al. Age-period-cohort analysis from 1990 to 2019 and prediction of oral cancer incidence from 2020 to 2049 in China. China Cancer. 2023;32(10):753\u20139. https:\/\/doi.org\/10.11735\/j.issn.1004-0242.2023.10.A006.","journal-title":"China Cancer"},{"key":"23416_CR22","doi-asserted-by":"publisher","unstructured":"Liu XW. Epidemiological characteristics and Trend analysis of malignant tumors incidence in Hainan, 2009~2016. Hainan Medical College; 2022. https:\/\/doi.org\/10.27952\/d.cnki.ghnyx.2020.000134.","DOI":"10.27952\/d.cnki.ghnyx.2020.000134"},{"issue":"46","key":"23416_CR23","doi-asserted-by":"publisher","first-page":"e31910","DOI":"10.1097\/MD.0000000000031910","volume":"101","author":"IA Chen","year":"2022","unstructured":"Chen IA, Chiu SF, Hung KC, et al. Malignant transformation of oral potentially malignant disorders in Taiwanese indigenous peoples: a nationwide retrospective cohort study. Medicine (Baltimore). 2022;101(46):e31910. https:\/\/doi.org\/10.1097\/MD.0000000000031910.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"23416_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1089\/jwh.2015.5708","volume":"25","author":"JC Felix","year":"2016","unstructured":"Felix JC, Lacey MJ, Miller JD, et al. The clinical and economic benefits of co-testing versus primary HPV testing for cervical cancer screening: a modeling analysis. J Womens Health (Larchmt). 2016;25(6):606\u201316. https:\/\/doi.org\/10.1089\/jwh.2015.5708.","journal-title":"J Womens Health (Larchmt)"},{"issue":"10159","key":"23416_CR25","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736\u201388. https:\/\/doi.org\/10.1016\/S0140-6736(18)32203-7.","journal-title":"Lancet"},{"issue":"7","key":"23416_CR26","doi-asserted-by":"publisher","first-page":"e0201552","DOI":"10.1371\/journal.pone.0201552","volume":"13","author":"DE Goldsbury","year":"2018","unstructured":"Goldsbury DE, Yap S, Weber MF, et al. Health services costs for cancer care in Australia: estimates from the 45 and up study. PLoS ONE. 2018;13(7):e0201552. https:\/\/doi.org\/10.1371\/journal.pone.0201552.","journal-title":"PLoS ONE"},{"key":"23416_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3969\/j.issn.1672-2566.2008.10.023","volume":"10","author":"C Du","year":"2008","unstructured":"Du C, Zheng J. Influencing factors of the medical expenses for oral cancer inpatients with surgical treatment. Chin Med Rec. 2008;10:33\u20135. https:\/\/doi.org\/10.3969\/j.issn.1672-2566.2008.10.023.","journal-title":"Chin Med Rec"},{"issue":"1","key":"23416_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/gyno.2000.5901","volume":"79","author":"SE Brooks","year":"2000","unstructured":"Brooks SE, Chen TT, Ghosh A, et al. Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix. Gynecol Oncol. 2000;79(1):107\u201315. https:\/\/doi.org\/10.1006\/gyno.2000.5901.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"23416_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12931-020-01607-6","volume":"22","author":"X Mao","year":"2021","unstructured":"Mao X, Liang C, Niu H, et al. Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry. Respir Res. 2021;22(1):7. https:\/\/doi.org\/10.1186\/s12931-020-01607-6.","journal-title":"Respir Res"},{"issue":"12","key":"23416_CR30","doi-asserted-by":"publisher","first-page":"e0260255","DOI":"10.1371\/journal.pone.0260255","volume":"16","author":"DH Wong","year":"2021","unstructured":"Wong DH, Mardock AL, Manrriquez EN, et al. Trends in extent of surgical cytoreduction for patients with ovarian cancer. PLoS ONE. 2021;16(12):e0260255. https:\/\/doi.org\/10.1371\/journal.pone.0260255.","journal-title":"PLoS ONE"},{"issue":"1","key":"23416_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12885-022-09590-5","volume":"22","author":"KT Han","year":"2022","unstructured":"Han KT, Chang J, Choi DW, et al. Association of institutional transition of cancer care with mortality in elderly patients with lung cancer: a retrospective cohort study using national claim data. BMC Cancer. 2022;22(1):452. https:\/\/doi.org\/10.1186\/s12885-022-09590-5.","journal-title":"BMC Cancer"},{"key":"23416_CR32","doi-asserted-by":"publisher","first-page":"100670","DOI":"10.1016\/j.lanwpc.2022.100670","volume":"32","author":"X Luo","year":"2022","unstructured":"Luo X, Du X, Huang L, et al. The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis. Lancet Reg Health West Pac. 2022;32:100670. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100670.","journal-title":"Lancet Reg Health West Pac"},{"key":"23416_CR33","doi-asserted-by":"publisher","first-page":"11016","DOI":"10.7189\/jogh.12.11016","volume":"12","author":"L Cai","year":"2022","unstructured":"Cai L, Tao T, Li H, Zhang Z, Zhang L, Li X. Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: a controlled interrupted time series study. J Glob Health. 2022;12:11016. https:\/\/doi.org\/10.7189\/jogh.12.11016.","journal-title":"J Glob Health"},{"issue":"7","key":"23416_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40273-022-01161-7","volume":"40","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Wei Y, Li H, et al. Prices and clinical benefit of national price-negotiated anticancer medicines in China. Pharmacoeconomics. 2002;40(7):715\u201324. https:\/\/doi.org\/10.1007\/s40273-022-01161-7.","journal-title":"Pharmacoeconomics"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23416-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:55:50Z","timestamp":1759920950000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23416"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23416-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3224970\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by Ethics Committee of Central South University (202005120).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3407"}}